EUVIMEDEUVIMED entdecken
Crossref

Potential of intestinal fatty acid binding protein (I-FABP) as a biomarker in ischemia and intestinal damage

M. R. Kuznetsov, A. I. Chernookov, A. A. Atayan, A. A. Ramazanov, O. N. Antonov, E. N. Belykh

Ambulatornaya khirurgiya = Ambulatory Surgery (Russia) · 20.11.2024 · 21 (2) · 229-237

DOI: 10.21518/akh2024-030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ambulatornaya khirurgiya = Ambulatory Surgery (Russia), online erschienen am 20.11.2024. Verfasst von M. R. Kuznetsov und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Violation of mesenteric circulation and intestinal damage are life-threatening conditions that require early diagnosis and, if necessary, prompt surgical intervention. Currently, the diagnosis of these conditions remains a difficult task due to the nonspecific nature of clinical symptoms andlimitations of existing diagnostic tools. The aim of the study is to study the potential of intestinal fatty acid binding protein (I-FABP) as a biomarker of mesenteric circulatory disorders and intestinal damage. The article discusses the structure and function of I-FABP, its expression and distribution in the small intestine, the mechanisms of release of I-FABP. Clinical studies of I-FABP levels in patients with these conditions are analyzed, assessing the accuracy of diagnosis and potential thresholds. The results of this study show that I-FABP has significant potential as a biomarker of OMI, intestinal ischemia and intestinal damage. Elevated levels of I-FABP have been observed in patients, and the diagnostic accuracy of I-FABP appears to be superior to other currently used biomarkers. However, further research is needed to determine optimal thresholds and establish standardized I-FABP measurement protocols. Thus, the introduction of I-FABP as a biomarker into clinical practice may lead to earlier diagnosis and improved outcomes in patients with intestinal ischemia.

Zitieren

APA

Kuznetsov, M. R., Chernookov, A. I., Atayan, A. A., Ramazanov, A. A., Antonov, O. N., & Belykh, E. N. (2024). Potential of intestinal fatty acid binding protein (I-FABP) as a biomarker in ischemia and intestinal damage. Ambulatornaya khirurgiya = Ambulatory Surgery (Russia), 21(2), 229-237. https://doi.org/10.21518/akh2024-030

Vancouver

Kuznetsov MR, Chernookov AI, Atayan AA, Ramazanov AA, Antonov ON, Belykh EN. Potential of intestinal fatty acid binding protein (I-FABP) as a biomarker in ischemia and intestinal damage. Ambulatornaya khirurgiya = Ambulatory Surgery (Russia). 2024;21(2):229-237. doi:10.21518/akh2024-030

BibTeX
@article{Kuznetsov2024,
  author = {Kuznetsov, M. R. and Chernookov, A. I. and Atayan, A. A. and Ramazanov, A. A. and Antonov, O. N. and Belykh, E. N.},
  title = {Potential of intestinal fatty acid binding protein (I-FABP) as a biomarker in ischemia and intestinal damage},
  journal = {Ambulatornaya khirurgiya = Ambulatory Surgery (Russia)},
  year = {2024},
  volume = {21},
  number = {2},
  pages = {229--237},
  doi = {10.21518/akh2024-030}
}
Kostenlos starten →